CMS is soliciting applications for organizations to participate in a new Oncology Care Model (OCM), which will test performance-based Medicare payment for episodes of care surrounding chemotherapy administration to cancer patients beginning in 2016. The model features a two-part payment system for participating practices: (1) a $160 monthly per-beneficiary-per-month payment for the duration of the episode, and (2) the potential for a performance-based payment for episodes of chemotherapy care to encourage practices to lower the total cost of care and improve care for beneficiaries during treatment episodes. The OCM is expected to start in the spring of 2016, and will last five years.
This article is presented for informational purposes only and is not intended to constitute legal advice.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.